跳至主要内容
临床试验/JPRN-UMIN000031777
JPRN-UMIN000031777已完成未知

A clinical study to evaluate the effects of imidazole dipeptides on improving fatigue sensation - A clinical study to evaluate the effects of imidazole dipeptides on improving fatigue sensation

Soiken Inc.0 个研究点目标入组 24 人开始时间: 2019年6月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Soiken Inc.
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subjects receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 2) Subjects having the chronic fatigue syndrome (CFS), or subjects deemed to have severe fatigue like idiopathic chronic fatigue by the investigator 3) Subjects having a medical history of chest pain or syncope 4) Subjects having an abnormality in the electrocardiogram 5) Subjects having a subjective symptom of low back pain, arthralgia or lumber hernia, disease of lower limbs, palpitations 6) Subjects who have the possibility of developing allergic symptoms by the test food 7) Subjects who take regularly pharmaceuticals or quasi-drugs which having the efficacy for recovery from fatigue or nutrient replenishment in case of physical fatigue. 8) Subjects who take regularly supplements of protein or amino acid drink 9) Subjects who take regularly Foods with Function Claims labeled the effect of attenuating fatigue sensation 10) Subjects who have a seasonal allergic rhinitis (cedar or Japanese cypress pollen) with moderate or severe symptoms 11) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 12) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study 13) Female subjects who are pregnant or lactating, or intending to become pregnant during the study 14) Subjects deemed unsuitable by the investigator

研究者

发起方
Soiken Inc.

相似试验